Search

Displaying results 5591 - 5600 of 10000 in total
  1. Drug

    Macadamia oil

    go.drugbank.com/drugs/DB14330
    Investigational

    Macadamia oil is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  2. Drug

    Tribulus terrestris

    go.drugbank.com/drugs/DB14358
    Investigational

    Tribulus terrestris is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  3. Drug

    LV305

    go.drugbank.com/drugs/DB17288
    Investigational

    LV305 is a lentiviral vector encoding NY-ESO-1 gene. LV305 is an active component of CMB305 along with [G305].[L47346]

  4. Drug

    QR-313

    go.drugbank.com/drugs/DB17867
    Investigational

    QR-313 is an antisense oligonucleotide targeting exon 73. It is being investigated for the treatment of dystrophic epidermolysis bullosa.[A259867]

  5. Drug

    CMC 001

    go.drugbank.com/drugs/DB05353
    Investigational

    CMC 001 is an orally administered MRI contrast agent in development for enhancement of the liver, bile ducts and gastrointestinal tract.

  6. Drug

    Inosinic Acid

    go.drugbank.com/drugs/DB04566
    Investigational

    A purine nucleotide which has hypoxanthine as the base and one phosphate group esterified to the sugar moiety.

  7. Drug

    Ethylmercurithiosalicylic acid

    go.drugbank.com/drugs/DB02731
    Experimental

    Ethylmercurithiosalicylic acid is a topical antiseptic used on skin and mucous membranes. It is also used as a preservative in pharmaceuticals.

  8. Drug

    Mevastatin

    go.drugbank.com/drugs/DB06693
    Experimental

    Mevastatin is a competitive inhibitor of HMG-Coenzyme A (HMG-CoA) reductase with a binding affinity 10,000 times greater than the HMG-CoA substrate itself. … During a search for antibiotic compounds produced by fungi in 1971, Akira Endo at Sankyo Co. (Japan) discovered a class of compounds that appeared to lower plasma cholesterol levels.

  9. Drug

    Abivertinib

    go.drugbank.com/drugs/DB15327
    Investigational

    Abivertinib is a tyrosine kinase inhibitor targeted against mutant forms of both human epidermal growth factor receptor (EGFR) and Bruton's tyrosine kinase (BTK). … cytokines at once, it may provide more pronounced clinical benefits as compared to agents targeting single pathways (e.g. interleukin-6 inhibitors).

  10. Drug

    ABX1100

    go.drugbank.com/drugs/DB17655
    Investigational

    ABX1100 is an investigational Centyrin-siRNA conjugate that targets the Gys1 gene, which encodes glycogen synthase 1 (Gys1), an enzyme that is responsible for glycogen synthesis in the muscle.